Representative Work

Taylor Cao Taylor Cao

Results

All Representative Work

Representative Work

Xanadu in its US$300-million synthetic at-the-market program

On May 21, 2026, Xanadu Qunatum Technologies Limited (Xanadu) announced that it has entered into a synthetic at-the-market equity facility for up to US$300 million (the program) with YA II PN, Ltd. (Yorkville Advisors). Xanadu intends to use the net proceeds, if any, for working capital and...

Lead Office: Toronto Date Announced: May 21, 2026 Value: US$300 million

Read more
Representative Work

FutureFit AI in its strategic investment from Achieve Partners

On April 13, 2026, FutureFit AI announced that it received a strategic investment from Achieve Partners to advance FutureFit AI’s mission of assisting more people navigate to better jobs at a faster and cheaper rate. FutureFit AI is workforce development technology platform. Osler, Hoskin...

Lead Office: Toronto Date Announced: April 13, 2026 Value: --

Read more
Representative Work

Clio in its US$1-billion acquisition of vLex and US$500-million Series G investment round

Osler advised Clio in its acquisition of vLex for US$1billion. This acquisition is the largest M&A transaction in the legal technology sector in history. Alongside this transaction, Clio announced a US $500-million Series G funding round at a US$5-billion valuation led by New Enterprise...

Lead Office: Vancouver Date Closed: November 10, 2025 Value: US$1billion

Read more
Representative Work

Xanadu in its cross-border de-SPAC transaction

On November 3, 2025, Xanadu Quantum Technologies Inc. (Xanadu) announced its going-public transaction by way of a business combination with Crane Harbor Acquisition Corporation (Crane Harbor), a special-purpose acquisition corporation (SPAC) listed on the Nasdaq Stock Market. The transaction...

Lead Office: Toronto Date Announced: November 3, 2025 Value: US$3 billion

Read more
Representative Work

Paine Schwartz Partners–backed HGS BioScience in its acquisition of NutriAg

On October 21, 2025, Paine Schwartz Partners–backed HGS BioScience announced it had acquired NutriAg Ltd., a Toronto-based innovator in bionutritional technologies. The combinations brings together HGS’s strength in humic acid-based products, U.S. market presence, and vertically...

Lead Office: Toronto Date Announced: October 21, 2025 Value: --

Read more
Representative Work

Dream Residential REIT in its US$354-million acquisition by Morgan Properties

On August 21, 2025, Dream Residential REIT announced that it has entered into an arrangement agreement to be acquired by Morgan Properties in an all-cash transaction valued at approximately US$354 million. This transaction marks the conclusion of the REIT’s previously announced strategic review...

Lead Office: Toronto Date Announced: August 21, 2025 Value: US$354 million

Read more
Representative Work

180 Degree Capital Corp. in its merger with Mount Logan Capital Inc.

On January 17, 2025, 180 Degree Capital announced an agreement to combine with Mount Logan Capital Inc. in all-stock transaction, establishing a U.S. exchange-listed, alternative asset management and insurance solutions platform with over $2.4 billion in assets under management. Pursuant to the...

Lead Office: Toronto Date Announced: January 17, 2025 Value: --

Read more
Representative Work

Spire Global in its agreement to sell its maritime business for approximately US$241 million

On November 13, 2024, Spire Global announced its agreement to sell its maritime business for approximately US$241 million to Kpler. Spire Global intends to use the proceeds of the sale to retire all outstanding debt and invest in near-term growth opportunities. The transaction consists of a...

Lead Office: Toronto Date Announced: November 12, 2024 Value: US$241 million

Read more
Representative Work

ParaPRO LLC in its US$89.5-million asset sale to Cipher Pharmaceuticals

On July 29, 2024, Cipher Pharmaceuticals Inc. announced the signing of a definitive asset purchase agreement with ParaPRO LLC (ParaPRO) and the closing of the acquisition of the global product rights for Natroba™ (Spinosad), as well as the commercial sales team in the United States for total...

Lead Office: Toronto Date Announced: July 29, 2024 Value: US$ 89.5 million

Read more
Representative Work

Penfund in connection with TorQuest’s acquisition of Mevotech

Osler advised Mevotech LP and its owner Penfund in connection with TorQuest’s acquisition of Mevotech. Mevotech is a North American leader in the engineering and design of driveline, steering, and suspension parts for the auto aftermarket. Penfund is a leading provider of capital to middle...

Lead Office: Toronto Date Announced: July 15, 2024 Value: --

Read more